-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tr9bT8CcbE6w84eSKmyHE3+gcu0/8wKfWtzokq7mKLV6vc2HzAIewSgov/+4hctj t6YUNfNogj5/N+s8wR7flg== 0000919574-10-001636.txt : 20100216 0000919574-10-001636.hdr.sgml : 20100215 20100216162904 ACCESSION NUMBER: 0000919574-10-001636 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100216 DATE AS OF CHANGE: 20100216 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ROTECH HEALTHCARE INC CENTRAL INDEX KEY: 0001175108 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 030408870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78993 FILM NUMBER: 10608411 BUSINESS ADDRESS: BUSINESS PHONE: 407-822-4600 MAIL ADDRESS: STREET 1: 2600 TECHNOLOGY DRIVE STREET 2: SUITE 300 CITY: ORLANDO STATE: FL ZIP: 32804 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CONTRARIAN CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001050417 IRS NUMBER: 931183419 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 411 W PUTNAM AVE STREET 2: STE 225 CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 2038628201 MAIL ADDRESS: STREET 1: 411 W PUTNAM AVE STREET 2: STE 225 CITY: GREENWICH STATE: CT ZIP: 06830 SC 13G/A 1 d1072834_13g-1.htm d1072834_13g-1.htm


 
OMB APPROVAL
OMB Number: 3235-0145
Expires: February 28, 2009
Estimated average burden
hours per response………11
   
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 3)*


Rotech Healthcare Inc.
(Name of Issuer)


Common Stock, par value $0.0001 per share
(Title of Class of Securities)


778669101
(CUSIP Number)


December 31, 2009
(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[X]  Rule 13d-1(b) *

[X]  Rule 13d-1(c) **

[_]  Rule 13d-1(d)


* This Schedule 13G is being filed pursuant to Rule 13d-1(b) by Contrarian Capital Management, L.L.C.

** This Schedule 13G is being filed pursuant to Rule 13d-1(c) by Contrarian Capital Fund I, L.P.

 
 

 


CUSIP No
778669101
   
     
1.
NAME OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
     
 
Contrarian Capital Management, L.L.C.
 
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)  [_]
   
(b)  [X]
     
3.
SEC USE ONLY
 
     
     
     
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
     
 
Delaware
 
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
     
5.
SOLE VOTING POWER
 
     
 
2,441,048
 
     
6.
SHARED VOTING POWER
 
     
 
1,366,570
 
     
7.
SOLE DISPOSITIVE POWER
 
     
 
2,441,048
 
     
8.
SHARED DISPOSITIVE POWER
 
     
 
1,366,570
 
     
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
 
3,807,618
 
     
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
 
   
[_]
     
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
     
 
14.93%
 
     
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
IA
 


 
 

 


CUSIP No
778669101
   
     
1.
NAME OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
     
 
Contrarian Capital Fund I, L.P.
 
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
(a)  [_]
   
(b)  [X]
     
3.
SEC USE ONLY
 
     
     
     
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
     
 
Delaware
 
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
     
5.
SOLE VOTING POWER
 
     
 
0
 
     
6.
SHARED VOTING POWER
 
     
 
1,366,570
 
     
7.
SOLE DISPOSITIVE POWER
 
     
 
0
 
     
8.
SHARED DISPOSITIVE POWER
 
     
 
1,366,570
 
     
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
 
1,366,570
 
     
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
 
   
[_]
     
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
     
 
5.36%
 
     
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
PN
 


 
 

 


CUSIP No
778669101
   
       
Item 1.
(a).
Name of Issuer:
 
       
   
Rotech Healthcare Inc.
 

 
(b).
Address of Issuer's Principal Executive Offices:
 
       
   
2600 Technology Drive
Suite 300
Orlando, Florida 32804
 

Item 2.
(a).
Name of Person Filing:
 
       
   
Contrarian Capital Management, L.L.C.
Contrarian Capital Fund I, L.P.
 

 
(b).
Address of Principal Business Office, or if None, Residence:
 
   
 
Contrarian Capital Management, L.L.C.
411 West Putnam Avenue, Suite 225
Greenwich, CT 06830
 
Contrarian Capital Fund I, L.P.
c/o Contrarian Capital Management, L.L.C.
411 West Putnam Avenue, Suite 225
 
   
Greenwich, CT 06830
 

 
(c).
Citizenship:
 
       
   
Contrarian Capital Management, L.L.C. – Delaware
Contrarian Capital Fund I, L.P. – Delaware
 

 
(d).
Title of Class of Securities:
 
       
   
Common Stock, par value $0.0001 per share
 

 
(e).
CUSIP Number:
 
       
   
778669101
 

Item 3.
 
If This Statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a

 
(a)
[_]
Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).

 
(b)
[_]
Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).

 
(c)
[_]
Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).

 
(d)
[_]
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 
(e)
[X]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

 
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);


 
 

 


 
(g)
[_]
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

 
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);

 
(i)
[_]
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 
(j)
[_]
Group, in accordance with s.240.13d-1(b)(1)(ii)(J).

 
Item 4.
Ownership.

 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 
(a)
Amount beneficially owned:
     
   
Contrarian Capital Management, L.L.C.: 3,807,618
Contrarian Capital Fund I, L.P. – 1,366,570

 
(b)
Percent of class:
     
   
Contrarian Capital Management, L.L.C.: 14.93%
Contrarian Capital Fund I, L.P. – 5.36%

 
 
(c)    Number of shares as to which Contrarian Capital Management, L.L.C. has:

   
(i)
Sole power to vote or to direct the vote
2,441,048
,
         
   
(ii)
Shared power to vote or to direct the vote
1,366,570
,
         
   
(iii)
Sole power to dispose or to direct the disposition of
2,441,048
,
         
   
(iv)
Shared power to dispose or to direct the disposition of
1,366,570
.

 
 
(c)    Number of shares as to which Contrarian Capital Fund I, L.P. has:

   
(i)
Sole power to vote or to direct the vote
0
,
         
   
(ii)
Shared power to vote or to direct the vote
1,366,570
,
         
   
(iii)
Sole power to dispose or to direct the disposition of
0
,
         
   
(iv)
Shared power to dispose or to direct the disposition of
1,366,570
.

Item 5.
Ownership of Five Percent or Less of a Class.

 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [_].
 
 
N/A
   


 
 

 


Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.

 
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified.  A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
 
 
N/A
   

Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

 
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary.  If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
 
 
N/A
   

Item 8.
Identification and Classification of Members of the Group.

 
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group.  If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
 
N/A
   

Item 9.
Notice of Dissolution of Group.

 
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity.  See Item 5.
 
 
N/A
   

Item 10.
Certification.

   
By signing below, each reporting person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


 
 

 


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 

 
February 16, 2010
   
 
 
CONTRARIAN CAPITAL MANAGEMENT, L.L.C.
 
 
/s/ Jon R. Bauer
 
Name: Jon R. Bauer
Title: Managing Member

 
 
CONTRARIAN CAPITAL FUND I, L.P.
By: Contrarian Capital Management, L.L.C.
 
 
/s/ Jon R. Bauer
 
Name: Jon R. Bauer
Title: Managing Member



 
 

 


 
Exhibit A
 
AGREEMENT
 
The undersigned agree that this Schedule 13G/A dated February 16, 2010 relating to the Common Stock, par value $0.0001 per share, of Rotech Healthcare Inc. shall be filed on behalf of the undersigned.
 
 
CONTRARIAN CAPITAL MANAGEMENT, L.L.C.
 
 
/s/ Jon R. Bauer
 
Name: Jon R. Bauer
Title: Managing Member

 
 
CONTRARIAN CAPITAL FUND I, L.P.
By: Contrarian Capital Management, L.L.C.
 
 
/s/ Jon R. Bauer
 
Name: Jon R. Bauer
Title: Managing Member



 



SK 01385 0001 1072834
-----END PRIVACY-ENHANCED MESSAGE-----